22 New Featured FDA 483s | September 20, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>>

Inspection End Date Company City/Local State/Region Country
3/17/2014 Antonio Capone Royal Oak MI United States
10/14/2015 Applied BioPhotonics Ltd. Chupei City, Hsinchu District Taiwan (Province of China)
12/10/2015 Biogen US Corporation Research Triangle Park NC United States
8/20/2015 Clear Image Devices LLC Ann Arbor MI United States
10/9/2015 Downing Labs, LLC Dallas TX United States
2/6/2014 Dr. Mahendra Sanapati, MD Evansville IN United States
4/25/2015 Hisun Pfizer Pharmaceuticals Co. Fuyang City China
8/27/2015 Innovative Surgical Designs, Inc. Bloomington IN United States
5/21/2014 Lawrence D. Petz, M.D. Los Angeles CA United States
12/3/2015 Medifocus, Inc. Columbia MD United States
11/5/2015 Next Health, LLC Norwalk CT United States
2/19/2015 Noland Surgical Inc Redding CA United States
3/19/2015 Pharmaforce Inc New Albany OH United States
10/15/2014 Puget Sound Blood Center and Program Renton WA United States
7/9/2014 Rajesh Sachdeo Trenton NJ United States
12/21/2015 Renner & Co Cary IL United States
1/6/2016 Rhode Island Novelty Inc. Fall River MA United States
1/31/2014 Shaukat Shah Stockton CA United States
11/2/2015 Silarx Pharmaceuticals, Inc. Carmel NY United States
3/21/2013 Slovin, Susan M.D., Ph.D. New York NY United States
5/14/2014 Steven J.Hager, D.O. Fresno CA United States
11/6/2015 WES Pharma Inc. Westminster MD United States

Learn more about how FDAzilla can help you achieve your quality and inspection preparation goals: get 483sInspector ProfilesEnforcement Analytics, and GMP Regulatory Intelligence. Contact me if you ever have questions at tony@fdazilla.com.

Like this post? Don't forget to share it!

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Govzilla Bug

Don’t miss out! Subscribe now

Experience the Power of Govzilla

Get your FREE account to search sites, inspections, & warning letters